Through
4/30
Penn Medicine Researcher Receives $3 million NCI Grant to Study Links between Liver Cancer and HIV
Vincent Lo Re, MD, MSCE, an assistant professor of Medicine in the division of Infectious Diseases and Epidemiology at the Perelman School of Medicine at the University of Pennsylvania, has been awarded a $3 million grant from the National
Three Penn Students Named HHMI Medical Research Fellows
Three graduate students from the University of Pennsylvania have been selected as Medical Research Fellows by the Howard Hughes Medical Institute (HHMI).
Testing Non-Breast/Ovarian Cancer Genes in High-Risk Women Leaves More Questions than Answers, Penn Study Finds
Running large, multi-gene sequencing panels to assess cancer risk is a growing trend in medicine as the price of the technology declines and more precise approaches to cancer care gain steam. The tests are particularly common among breast and ovarian cancer patients.
Penn Medicine and Johns Hopkins: HIV Infections Drop, but U.S. Falls Short of National Goals
The number of new HIV infections and the transmission rate in the United States dropped by 11 and 17 percent, respectively, between 2010 and 2015, but fell short of the goals put forth by President Obama’s U.S.
Cholesterol Levels, Not Statins, Influence Colorectal Cancer Risk, Penn Study Suggests
Long-term use of the cholesterol-lowering drugs known as statins does not appear to decrease a patient’s risk of colorectal cancer, suggests a new, large case-control study from Penn Medicine researchers published this week in&
Penn-led Team Presents Results from Clinical Trial of Personalized Cellular Therapy in Brain Tumor Patients
Immune cells engineered to seek out and attack a type of deadly brain cancer known as glioblastoma (GBM) were found to have an acceptable safety profile and successfully migrate to and infiltrate tumors, researchers from Penn Medicine and Harvard University reported at the
Penn Medicine Presents Evidence Showing New Drug Combination May Improve Outcomes for Women with Advanced Breast Cancer when Administered Before Surgery
Results from the I-SPY 2 trial show that giving patients with HER2-positive invasive breast cancer a combination of the drugs trastuzumab emtansine (T-DM1) and pertuzumab before surgery was more beneficial than the combination of paclitaxel plus trastuzumab.
Proactively Treating HIV Patients at Risk for Tuberculosis with Multi-Drug TB Regimens Doesn't Save More Lives
The number one killer of HIV patients in resource-limited areas, including parts of Africa and India, is tuberculosis (TB), underscoring the need for optimal treatments and effective strategies to address this deadly co-infection.
Tapping into Twitter to Help Recruit Cancer Patients into #ClinicalTrials
Twitter may be an effective, untapped resource to stimulate interest in cancer clinical trials and boost enrollment, physicians at the Abramson Cancer Center of the University of Pennsylvaniasuggest in a new research letter in JAMA Oncology. Analyzing thousands of lung cancer tweets on the social media site revealed that a surprisingly large number were about clinical trials, particularly ones on immunotherapy, although none were used for recruitment.
New Breast Cancer Drug May be Effective against Other Types of Cancer, Abramson Cancer Center Experts Find
Palbociclib, a new oral drug whose efficacy in combating breast cancer has been demonstrated alone and in combination with endocrine therapy, also has potential to combat other types of cancer, according to a literature review and additional original research conducted by experts at the